ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025
Hsa_circRNA_0101125 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma via miR-143-3p/ZNF148 Axis.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hsa_circRNA_0101125 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma via miR-143-3p/ZNF148 Axis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Esophageal squamous cell carcinoma (ESCC) is a highly invasive and metastatic malignancy. Circular RNAs (circRNAs), including hsa_circRNA_0101125, have been implicated in regulating cancer metastasis. But its potential roles in ESCC remain underexplored, particularly in relation to miR-143-3p. This study aimed to investigate the role of hsa_circRNA_0101125/miR-143-3p in the occurrence and development of ESCC. KYSE150 and ECA109 cells were used as in vitro models to evaluate the biological effects of hsa_circRNA_0101125. The interaction between ZNF148 and miR-143-3p was confirmed by dual-luciferase assay. To assess the functional role of this pathway, cells were transfected with sh-hsa_circRNA_0101125 vectors and/or miR-143-3p inhibitors, followed by assays for cell viability (CCK-8), migration (wound healing assay), and invasion (Transwell assay). Transcriptions and expressions of hsa_circRNA_0101125, miR-143-3p, and ZNF148 were measured by RT-qPCR and western blot. Results showed that hsa_circRNA_0101125 was localized in the cytoplasm and negatively regulated miR-143-3p, which targeted ZNF148. Inhibition of hsa_circRNA_0101125 significantly reduced cell viability, migration, and invasion, downregulated ZNF148 and Vimentin, and upregulated miR-143-3p and E-cadherin expressions. In contrast, downregulating miR-143-3p abolished these effects. Therefore, hsa_circRNA_0101125 promotes the proliferation, migration, and invasion of ESCC cells by inhibiting the expression of miR-143-3p.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.